Rosen Law Firm Encourages FLOW Cryptocurrency Investors to Inquire About Securities Class Action Investigation

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the...

Orbis International's Flying Eye Hospital Arrives in Peru to Expand Access to Essential Eye Care

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting...

Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of...

SAMARITAN'S PURSE EBOLA TREATMENT CENTERS OPEN IN THE EPICENTER OF THE DEADLY OUTBREAK

Bitcoin Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement

HorseWood & HorseBoost [Exclusive Report 2026] The Horse Gelatin Trick Male Enhancement Or Why Talking About Natural Vitality Supplement...

Over 100 Organizations Thank America’s Blood Donors on World Blood Donor Day

Tradr to Ring Opening Bell at Cboe to Celebrate SpaceX ETF Launches

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Via Transportation, Inc. Investors to Secure Counsel Before Important Deadline in Securities...

Readout - Prime Minister Carney meets with President of Ireland Catherine Connolly

Ruvi AI (RUVI) Announces Phase 3 Has Reached 90% Sellout as Investors Race to Secure Remaining Tokens at $0.02

SES AI DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages SES AI Corporation Investors with Losses in Excess of $100K to Secure Counsel...

/R E P E A T -- MEDIA ADVISORY - FEDERAL GOVERNMENT TO MAKE HOUSING ANNOUNCEMENT IN WINNIPEG/

MUSSO E80 Muse Sees Strong U.S. Sales Following European Breakout and MUSE Design Award Win

Therapist Launches in UK - Built on Leadership, Creative & HIV Lived Experience

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European...

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and...

Solar-Powered Mobile Surveillance Trailers for Off-Grid Sites | Site View Pro